RT Book, Section
A1 Roldan, Carlos J.
A2 Reichman, Eric F.
SR Print(0)
ID 1159796759
T1 Automatic Implantable Cardioverter-Defibrillator Assessment
T2 Reichman's Emergency Medicine Procedures, 3e
YR 2018
FD 2018
PB McGraw-Hill Education
PP New York, NY
SN 9781259861925
LK accessemergencymedicine.mhmedical.com/content.aspx?aid=1159796759
RD 2024/04/25
AB The  introduction  of  implantable  cardioverter-defibrillator  (ICD)  technology  has  revolutionized  the  fields  of  cardiology  and  electrophysiology.  More  than  100,000  such  devices  are  implanted  annually  in  the  United  States  alone.  ICDs  allow  life-threatening  ventricular  tachycardia  and  ventricular  fibrillation  to  be  safely  controlled  and  benefit  patients  at  risk  for  sudden  cardiac  death.  Multiple  studies  have  examined  the  prophylactic  indication  for  ICD  therapy  in  high-risk  groups.1-7  The  ICD  has  become  a  more  common  therapeutic  option  for  Brugada  syndrome,  prolonged  QT  syndrome,  and  cardiomyopathies.8